Physician
Ajtai, Bela
Ajtai, Bela was paid $140K by Medicaid between Jan 2018 and Nov 2024, across 20 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 42% of everything it billed.
33Billing provider infoAJTAI, BELA
AMHERST, NY 14226
AMHERST, NY 14226
33aNPI1316155500assigned 05/19/2007
33bProvider typeNeurology Physician
28Total paid$140K
24GClaims13,172
24DCodes billed20
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers
Next to other Neurology Physician providers in New York
Rank by total paid#112 of 623
Median peer was paid$9K
This provider vs. median15×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 1,029 | $6K | |
| 2019 | 1,480 | $11K | |
| 2020 | 1,539 | $14K | |
| 2021 | 2,339 | $21K | |
| 2022 | 2,213 | $21K | |
| 2023 | 1,958 | $28K | |
| 2024incomplete | 2,614 | $39K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 42% | 1,906 | 1,904 | $59K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 16% | 1,852 | 1,257 | $22K |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | 14% | 1,370 | 1,266 | $20K |
| 70551 | Magnetic resonance imaging, brain; without contrast material | 9.3% | 164 | 163 | $13K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 7.5% | 519 | 519 | $11K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 4.2% | 1,179 | 1,000 | $6K |
| 96375 | Therapeutic injection; each additional sequential IV push | 2.1% | 1,295 | 1,046 | $3K |
| 96367 | 2.1% | 519 | 440 | $3K | |
| J7050 | Infusion, normal saline solution, 250 cc | <1% | 2,917 | 2,444 | $887.29 |
| 96415 | <1% | 213 | 187 | $866.39 | |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | <1% | 30 | 30 | $510.59 |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 29 | 24 | $329.64 |
8 more codes
| J2919 | Injection, methylprednisolone sodium succinate, 5 mg | <1% | 43 | $217.32 |
| 64450 | <1% | 12 | $165.93 | |
| 64405 | <1% | 12 | $158.31 | |
| J3475 | Injection, magnesium sulfate, per 500 mg | <1% | 276 | $97.03 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 257 | $88.54 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 267 | $85.33 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 107 | $26.41 |
| G2211 | Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) | 0% | 205 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.